IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Influx Healthtech Ltd.
Issue Open Date 18-Jun-25  
Issue Closing Date 20-Jun-25  
Application Money 100  
Allotment Money  
Price Band 91 - 96  
Minimium Application No. 1200  
Issue Size (Shares) 4364400  
Market Lot 1.00  
Objective
1. Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division.2. Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division.3. Purchase of Machineries for Homecare and Cosmetic Division.4. General Corporate Purposes.
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors     418878000   NA  
Qualified Institutional Buyers     159818400   NA  
Retail Individual Investors     238842000   NA  
Business Description
Influx Healthtech Limited is a Mumbai-based, healthcare focused company specialising in contract manufacturing. Since its inception in 2020, the company has established itself as a reliable Contract Development and Manufacturing Organization (CDMO), offering s
more...
Promoter's Holding
Total Share Capital   18123864  
Offered to Public   4364400  
Promoter's Holding (Pre-Issue)   99.86  
Promoter's Holding (Post-Issue)   73.53  
Address
109
Ghanshyam Enclave Premises
Co- Op Soc Plot No. 856
Laljipada
Kandivali (West)
Mumbai ,
Maharashtra ,
400067
Phone: 7045997809
Email: cs@influxhealthtceh.com
Website: www.influxhealthtech.com
Registrar
Maashitla Securities Pvt Ltd.
451
Krishna Apra Business
Square
Netaji Subhash Place

Pitampura
New Delhi
Listed at
NSE
Lead Manager
Rarever Financial Advisors Pvt Ltd.
Promoters
Abdul Ganee Abdul Rasul Chandniwala
Munir Abdul Ganee Chandniwala
Shirin Munir Ahmed Chandniwala
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.